吸烟和肝脏疾病:关于病变发生,进展和治疗影响的最新综述
Gasser El-Azab1, Ehab Elkhouly2, Rania Abouyoussef2
1Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Shebeen El-Kom, Egypt. g_elazab@liver.menofia.edu.eg.
Clinical and experimental medicine
|December 3, 2025
概括
吸烟显著损害肝脏健康,恶化诸如MASLD之类的疾病,增加癌症风险. 戒烟对于管理所有肝脏疾病和改善移植结果至关重要.
科学领域:
- 肝病学和公共卫生
- 毒理学和致癌的产生.
背景情况:
- 烟草吸烟是全球主要可预防的死亡原因之一.
- 它对肝脏疾病的影响在历史上被低估了,与呼吸道和心血管的影响相比.
- 新出现的证据强调吸烟是各种肝脏疾病的独立风险因素.
研究的目的:
- 综合目前有关吸烟对肝脏健康多方面的影响的知识.
- 审查吸烟与肝损伤,纤维化,癌症和移植并发症有关的机制.
- 探索电子烟的使用,并强调戒烟策略.
主要方法:
- 对现有研究和临床数据进行全面的文献审查.
- 对调查吸烟对各种肝脏疾病 (MASLD,ALD,病毒性肝炎,PBC,HCC) 影响的研究分析.
- 检查包括氧化应激,炎症和致癌物质在内的机制.
主要成果:
- 吸烟会对许多肝脏疾病的发病率,严重程度和结果产生负面影响.
- 它与肝移植接受者的并发症和死亡率增加有关.
- 机制包括直接毒性,免疫失调,氧化应激和致癌物.
结论:
- 戒烟是肝脏疾病所有阶段的重要治疗干预措施.
- 医疗保健专业人员和患者需要提高对吸烟对肝脏影响的认识.
- 有针对性的干预措施对于减少吸烟相关的肝病负担至关重要.
相关概念视频
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Stress Prevention and Stress Management Techniques IV
214
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
214
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K


